Peptide Grading
Research peptide
Adamax
From
$35.00
Vendors
7
Lab tested
1 COAs
Key benefits
- Modified form of Semax
- Marketed for focus and memory
Adamax is a good example of how fast this market moves. It showed up on vendor sites a couple of years ago as a "stronger Semax," and nearly every page describing it repeats the same lines. When I went looking for primary literature on Adamax itself, I couldn't find any. What exists is the research on its two parent compounds, and a design idea that borrows from both.
I'll lay out what's known, what's borrowed, and what's just marketing. On Peptide Grading, we list the research-labeled vials with sizes, price per mg, and COAs side by side. A listing doesn't mean any of the claims below have been shown.
Typical dose
300–600 mcg
Once daily (morning)
Route
Intranasal
Administered intranasally, typically in the morning for cognitive enhancement. Some protocols split the dose between morning and early afternoon. Avoid evening dosing if stimulatory effects are noted. Each nasal spray delivers approximately 50-100mcg per actuation.
Cycle
5–7 days on, 2–3 days off
Typical duration
Storage
Store in cool, dry place; protect from light
Follow vendor guidance
Marketplace
Compare all Adamax vendors
Prices per size, coupon codes, lab reports and shipping.
| Vendor | Price | Coupon | Lab test | Shipping | |
|---|---|---|---|---|---|
 TrustedPeps 10 mg | $35.00 Lowest price$3.50/mg | Not on file | 3 days
| Buy | |
$44.99 $9.00/mg | Not on file | 3 days
| Buy | ||
Amino Club 15 mg | $89.99 $6.00/mg | Not on file | 1–4 days
| Buy | |
American Peptides 10 mg | $90.00 $9.00/mg | 1 COA | 1-2 days
| Buy | |
Crownwell Research 10 mg | $99.00 $9.90/mg | Not on file | 1-5 days
| Buy | |
LA Peptides 10 mg | $99.99 $10.00/mg | Not on file | 2–5 days
| Buy | |
Biologix Labs 5 mg | $119.98$149.97 −20%$24.00/mg | Not on file | 2 Days
| Buy |
United States
What is Adamax?
Adamax is an investigational research peptide commonly described as a modified Semax-related ACTH analogue
Adamax
Compound
Adamax
Alternative name
Adamax; DW 1032 in some vendor catalogs
Compound type
Synthetic ACTH-analogue research peptide
Sequence length
Not reliably
N-terminal extension
Commonly reported N-acetylation
Key modification
N-Terminal Acetylation and C-Terminal Adamantane Group
Molecular weight
1,032.23 g/mol
Registry identifier
No authoritative
Research status
Investigational
Medsafe listed Adamax among ACTH analogues in its 2025 peptide-classification review, but that record does not establish an exact sequence, formula, or molecular weight. Lot-specific HPLC-MS documentation should be used when evaluating identity.
Where the Idea Comes From
Semax was developed in Russia, at the Institute of Molecular Genetics, as a stripped-down piece of the ACTH hormone that kept the brain-related activity and dropped the hormonal effects. It's registered as a medicine in Russia, so there's real clinical history, though most of it was done there and has limited Western replication. Its weakness is simple: it's a short peptide that the body breaks down within minutes.
Adamantane is the second ingredient. It's a rigid, oily cage-shaped molecule that's already used in approved drugs like amantadine and memantine, where it helps molecules cross into the brain. A neuroprotective peptide called P021, studied in Alzheimer's mouse models, uses the same trick at its tail end. Adamax takes Semax's sequence, adds an acetyl cap up front to slow breakdown, and swaps in P021's adamantane ending. On paper it's a sensible design. On paper is the key phrase.
What the Lab Work Covers
Honestly, nothing specific to Adamax. The areas vendors cite, such as BDNF signaling, neuroprotection, and stress response, come from Semax studies, mostly in rats. Whether the adamantane version behaves the same way, lasts longer, or reaches the brain better is a hypothesis. I found no published pharmacokinetics for it.
How It Stacks Up Against Its Relatives
| Compound | Main structural feature | Length | Key distinction |
|---|---|---|---|
| Semax | 7-aa ACTH fragment | Registered medicine in Russia | |
| N-Acetyl Semax Amidate | Semax with acetyl and amide caps | Unapproved, no adamantane | |
| Adamax | Same, plus adamantane ending | Unapproved designer analog | |
| Selank | Different peptide (tuftsin analog) | Registered in Russia |
The "Super Semax" Claim
You'll see Adamax called the most potent member of the family, repeated across vendor pages. I couldn't trace that to a study. It's reasoning by analogy: adamantane helped other molecules, so it should help this one. Plausible, untested.
Where Regulators Have Landed
Adamax isn't approved in any country. In mid-2025, New Zealand's Medsafe published a classification review that listed it among peptides suggested for prescription-only status, and its entry noted it had been identified as a designer drug in border seizures. That's a regulator treating it as a designer analog, not as a vetted compound.
WADA Status
Adamax isn't approved by any health authority, so it should fall under S0 (non-approved substances), which is prohibited at all times. I couldn't find a WADA statement naming it specifically, so athletes should confirm with their anti-doping organization.
Research reference note
COA First, Claims Later
With a compound this new, the only thing you can actually check is the paperwork. Look at the mass spec and lot number before anything else, then compare what's left on [Peptide Grading](#vendor-listings).
FAQ
Frequently asked questions.
A designer analog of Semax with an acetyl cap at the front and an adamantane-bearing ending borrowed from P021.